CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Levitee Labs Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Levitee Labs Inc
215 800 West Pender St
Vancouver, BC  V6C 1J8  Canada Ticker: LVTLVT
Business Summary
Levitee Labs Inc. is a Canada-based integrative wellness company. The Company focuses on the centralization of integrative wellness assets. It is involved in transforming the traditional landscape of mental health, addiction, and pain management treatments through evidence-based complementary medicines and psychedelic therapies through its portfolio of wellness assets. The Company’s portfolio of assets includes Levitee Clinics, Levitee Pharmacies, Levitee Nutraceuticals and Sporeo. Levitee Clinics is a group of five operating addiction and pain treatment clinics in Alberta. Levitee Pharmacies includes three pharmacies operating in Alberta specialized in filling prescriptions for patients with substance use disorders, mental health conditions, and chronic pain. Levitee Nutraceuticals includes MONKE Nutra, Ojio, Earth Shift and Earth Circle Organics. Sporeo products are available through retail, wholesale, and ecommerce channels and defragments the mushroom cultivation ecosystem.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20229/30/2021-----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
5122 Drugs, drug proprietaries, and druggists' sundries
8093 Specialty outpatient facilities, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director PouyaFarmand 30 11/30/2020 11/30/2020
Chief Financial Officer MasonDarabi 37 1/18/2021 1/18/2021
Chief Operating Officer, Director KellyAbbott 33 11/30/2020 11/30/2020
4 additional Officers and Directors records available in full report.

Business Names
Business Name
7H7
LVT
LVTTF

General Information
Outstanding Shares: 75,823,886 (As of 6/30/2022)
Stock Exchange: CNQ


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, October 30, 2024